LONG TERM Outcomes of Pediatric Patients with Malignant and NON-Malignant Disorders Receiving Α/Β T-CELL Depleted HLA-Haploidentical Hematopoietic STEM CELL Transplantation (HSCT) Followed by Infusion of BPX-501 T CELLS (DONOR T CELLS Transduced with IC9
2017 ◽
Vol 23
(3)
◽
pp. S122-S123
2013 ◽
Vol 19
(2)
◽
pp. S225
2014 ◽
Vol 20
(5)
◽
pp. 655-661
◽
2007 ◽
Vol 0
(0)
◽
pp. 071115151007004-???
◽
2014 ◽
Vol 20
(2)
◽
pp. S74
2016 ◽
Vol 22
(3)
◽
pp. S139